According to Kura Oncology
's latest financial reports the company has a price-to-book ratio of 8.64756.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.63 | -39.37% |
2023-12-31 | 2.69 | 36.1% |
2022-12-31 | 1.98 | 7.4% |
2021-12-31 | 1.84 | -47.9% |
2020-12-31 | 3.53 | 23.77% |
2019-12-31 | 2.85 | -14.27% |
2018-12-31 | 3.33 | -42.52% |
2017-12-31 | 5.79 | 161.15% |
2016-12-31 | 2.22 | 1.38% |
2015-12-31 | 2.19 |